FilingSEC EDGAR8-K
Turn Therapeutics Appoints Former CDC Director Robert R. Redfield as CSO
· SEC accepted
StagePersonnel
Filing content
Turn Therapeutics appointed former U.S. CDC Director Robert R. Redfield, M.D., as Chief Scientific Officer. Dr. Redfield will lead the scientific strategy and clinical design for the company's lead candidate, GX-03.
AI summary of the filing. Please also check the source.Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…